Results 31 to 40 of about 51,036 (300)

The risk of preterm labor after COVID-19 vaccination before and during pregnancy

Frontiers in Drug Safety and Regulation, 2023
Background: Pregnant women have a higher risk of severe illness and adverse pregnancy outcomes due to a SARS-CoV-2 infection. COVID-19 vaccination can prevent (severe) infection.
M. de Feijter, L. C. M. Vissers, L. Davidson, A. C. Kant, A. C. Kant, P. J. Woestenberg   +5 more
doaj   +1 more source

Hospital doctors' views and concerns about pharmacovigilance [PDF]

, 2015
Purpose: The aim of the study was to evaluate the opinions and concerns of hospital doctors about adverse drug reactions (ADRs) and pharmacovigilance.
Pedrós, Consuelo, Quijada Manuitt, M. Angeles, Arnau de Bolós, Josep M., Simón, C. P., Vallano Ferraz, Antonio, Castañeda, P. F., Quintana, B., Esterlich, E.   +7 more
core   +1 more source

Medication errors safety signals COVID-19-related Moroccan Pv database [PDF]

E3S Web of Conferences, 2021
On March 23, 2020, the Moroccan Ministry of Health issued a circular authorizing the off label use of hydroxychloroquine or chloroquine in combination with azythromycin as first-line treatment for all COVID-19 patients. The aim of this study is to detect,
Sefiani Houda, Benabdallah Ghita, Tebaa Amina, Soulaymani Bencheikh Rachida   +3 more
doaj   +1 more source

An evaluation of postmarketing reports of hyperglycaemia associated with dolutegravir for treatment of HIV in Eswatini

AIDS Research and Therapy, 2022
Background Dolutegravir (DTG) is an Integrase Strand Transfer Inhibitor (INSTI) indicated in combination with other antiretroviral agents for the treatment of HIV infection.
Alemayehu L. Duga, Sibongile Magongo, Siphesihle Nhlabatsi, Denis O. Ladwar, Linda Härmark, Leàn Rolfes   +5 more
doaj   +1 more source

Designing adverse event forms for real-world reporting: participatory research in Uganda. [PDF]

, 2012
The wide-scale roll-out of artemisinin combination therapies (ACTs) for the treatment of malaria should be accompanied by continued surveillance of their safety.
Clare I R Chandler, Sarah G Staedke, Staedke, Sarah, Dianne J. Terlouw (174559), David G Lalloo, Emma C. Davies (174533), Lalloo David G., Innocent Simeon H. S., Davies, Emma C, Chandler, Clare IR, Simeon H S Innocent, Charles Kalumuna, Chandler, Clare I.R., David G. Lalloo (101770), Innocent, Simeon H.S., Terlouw, Dianne J, Lalloo, David G, Haaland, Ane, Staedke Sarah G., Innocent, Simeon HS, Ane Haaland (174580), Dianne J Terlouw, Terlouw, Anja, Terlouw Dianne J., Charles Kalumuna (174550), Staedke, Sarah G, Chandler Clare I. R., Kalumuna, Charles, Davies, Emma C., Clare I. R. Chandler (174538), Lalloo, David; id_orcid, Sarah G. Staedke (174569), Davies Emma C., Emma C Davies, Kalumuna Charles, Ane Haaland, Simeon H. S. Innocent (174543), Haaland Ane   +37 more
core   +2 more sources

Pharmacovigilance during mass immunization campaign with MenAfrivac τm in Cameroon [PDF]

, 2015
Background. Immunization is one of the most cost effective public health interventions and is estimated to have greatly reduced diseases, disabilities, deaths, and inequities worldwide.
Ateudjieu, Jerome
core   +1 more source

Vaccination process evaluation at COVID-19 vaccination centers in Lebanon: a national study

Journal of Pharmaceutical Policy and Practice, 2022
Background Upon the authorization of COVID-19 vaccines worldwide, national and international standards were developed to help integrate mass COVID-19 immunization campaigns into the healthcare network.
Abeer Zeitoun, Souheil Hallit, Maya Helali, Sirine Chehade, Carla Allam, Aya Ibrahim, Hani Dimassi, Rita Karam   +7 more
doaj   +1 more source

Evaluation of Pharmacovigilance System in Iran [PDF]

International Journal of Health Policy and Management, 2022
BackgroundEvaluating a pharmacovigilance system helps identify its deficiencies and could facilitate measures to remedy and improve the quantity and quality of adverse drug reaction (ADR) reports and other opportunities for pharmacovigilance systems ...
Malahat Khalili, Hamid Sharifi, Bita Mesgarpour, Mehrnaz Kheirandish, Sten Olsson, Naghmeh Javidnikou, Ali Akbar Haghdoost   +6 more
doaj   +1 more source

Safety Monitoring of mRNA COVID-19 Vaccines in Children Aged 5 to 11 Years by Using EudraVigilance Pharmacovigilance Database: The CoVaxChild Study

Vaccines, 2023
Although the safety profiles of mRNA COVID-19 vaccines (mRNA-1273 and BNT162b2) were evaluated in pre-authorization clinical trials, real-world data allow us to better define their benefit/risk ratio in the paediatric population.
Alessia Zinzi, Mario Gaio, Valerio Liguori, Rosanna Ruggiero, Marina Tesorone, Francesco Rossi, Concetta Rafaniello, Annalisa Capuano   +7 more
doaj   +1 more source

Pharmacovigilance in radiopharmaceuticals

Indian Journal of Nuclear Medicine, 2016
Indian Pharmacopoeia Commission is Committed for maintaining the standards of drugs including Radiopharmaceuticals (RPs) by publishing Indian Pharmacopoeia. These RPs are being used in India for diagnostic or therapeutic purpose. RPs though contain relatively small quantities of active ingredient and administered in small volumes could cause some ...
Kumar, Rishi, Kalaiselvan, Vivekanandan, Kumar, Rakesh, Verma, Ravendra, Singh, Gyanendra Nath   +4 more
openaire   +3 more sources